Trauma Molecular Processes
ConditionTraumatic Brain Injury
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMario Negri Institute for Pharmacological Research
About this trial
The TRAUMAP study will function as a brain tissue repository for biopsy specimens from patients with traumatic brain injury undergoing brain surgery for contusion removal.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged ≥18 years.
Diagnosis of traumatic brain injury (TBI).
Admission to the intensive care unit.
Clinical indication for neurosurgical evacuation of a cerebral contusion.
Disqualifiers
Coagulation disorders or other contraindications to the planned neurosurgical procedure.
Trial population
Adult subjects
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Tissue Used for Future Research Studies
Tissue collected through the study will be stored and used in future approved research studies
Time frame
Time frame as clinically indicated, maximum 2 weeks after TBISponsors and contacts
Click on the lead sponsor to view all of their trials.
Mario Negri Institute for Pharmacological Research
Lead sponsor
A.O. Ospedale Papa Giovanni XXIII
Collaborator
Fondazione IRCCS San Gerardo dei Tintori
Collaborator
Source ClinicalTrials.gov